SimBioSys
SimBioSys is a healthcare technology company specializing in precision medicine and cancer treatment solutions. They offer innovative tools like TumorSight Viz and TumorSight Risk, which utilize AI to enhance cancer diagnostics and treatment planning for healthcare providers. Their solutions aim to improve patient outcomes by providing detailed insights into tumor biology and treatment options.
Employees
29
Founded
2018
Ownership
venture capital
Est. revenue
$6.5M
Headcount
29
Website visitors
48,120
Workforce
Headcount by location
- United States100%
Split by department
- Engineering & R&D40%
- Founder, Owner & Executive30%
- Marketing & Comms10%
- Sales10%
- Other10%
Seniority distribution
- Less than 5 years37%
- 5 to 10 years32%
- 30 years and more21%
- 10 to 20 years11%
Funding
$23.1M
Raised to date
DateTypeAmountInvestors
- 29 Mar 2026Undefined FundingUndisclosedAV8 Ventures, Calculus Venture Capital, Mayo Clinic, Northpond Ventures
- 20 Dec 2024Undefined Funding$5.2M—
4 earlier rounds, with their terms and sources.
Investors
InvestorCompanies backedCountry
National Cancer Institute (NCI)The National Cancer Institute (NCI) is a U.S. federal government agency within the NIH that leads the nation’s cancer research, training, and information dissemination. It offers free cancer information services, digital resources, research grants294United States
Mayo ClinicMayo Clinic is a not‑for‑profit academic medical center that integrates clinical practice, education, and research. It delivers comprehensive patient care, offers medical education, conducts research, and provides digital health platforms193United States
Northpond VenturesNorthpond Ventures is a venture capital firm that focuses on advancing science and technology-driven businesses. They provide funding and support to innovative companies in the biotechnology and life sciences sectors, collaborating with leading93United States
AV8 VenturesAV8 Ventures is a venture capital firm that specializes in investing in early-stage startups across healthcare, enterprise, financial services, and deep-tech sectors. The firm provides capital and strategic guidance to entrepreneurs, helping them29United States
Revenue
$6.5M
EBITDA
24.8M
Revenue source: Modeled estimate
Recent news
- SimBioSys and Ferrum Health partner to expand access to ai-powered surgical planning Through Ferrum's AI governance suite.partners with
- SimBioSys to showcase new advancements in ai-powered surgical planning at the American Society of Breast Surgeons (ASBrS) Annual Meeting.attends event
- SimBioSys Highlights Clinical Data Demonstrating AI Digital Twin Performance Comparable to Radiologists at 43rd Annual Miami Breast Cancer Conference(R)attends event
- SimBioSys Appoints Senthil Periaswamy as Chief AI & Technology Officerhires
People
How the team has changed month by month — joiners, leavers and where the hiring is going
Connections
Who at your firm already knows someone here, and how warm the path is
In the app
The full SimBioSys profile lives in Inven.
Get in touch
Your competitors are already on Inven
See how Inven turns hours of manual research into a single, structured workflow.
Business Brokers
Investment Banking
Private Equity
M&A
Consulting
Venture Capital
Corporate Development
Search Funds
Business Brokers
Investment Banking
Private Equity
M&A
Consulting
Venture Capital
Corporate Development
Search Funds